Gaush Meditech Ltd (FRA:F7Y)

Market Cap	135.98M
Revenue (ttm)	171.09M
Net Income (ttm)	12.11M
Shares Out	n/a
EPS (ttm)	0.08
PE Ratio	11.23
Forward PE	n/a
Dividend	0.03 (3.70%)
Ex-Dividend Date	Jun 23, 2025

Volume	n/a
Average Volume	110
Open	0.8950
Previous Close	0.9450
Day's Range	0.8950 - 0.8950
52-Week Range	0.5700 - 1.4800
Beta	n/a
RSI	57.79
Earnings Date	Aug 22, 2025

About Gaush Meditech

Gaush Meditech Ltd. engages in the research and development, production, and distribution of ophthalmic medical equipment and consumables, and the provision of technical services to end customers. The company’s product portfolio comprising proprietary products, which it develops and manufactures, as well as distribution products of its brand partners, which it distributes, covering seven ophthalmology sub-specialties where ophthalmic medical devices are utilized for diagnosis, treatment, or surgeries, being vitreoretinal diseases, cataracts, re...

• Industry: Medical, Dental, and Hospital Equipment and Supplies
• Founded: 1998
• Employees: 884
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: F7Y

Financial Performance

In 2024, Gaush Meditech's revenue was 1.43 billion, an increase of 1.58% compared to the previous year's 1.41 billion. Earnings were 92.39 million, a decrease of -46.75%.

Financial numbers in CNY